http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107952074-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-907 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-90 |
filingDate | 2017-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107952074-B |
titleOfInvention | Use of agents inhibiting SMC1B gene expression |
abstract | The invention provides application of an agent for inhibiting SMC1B gene expression in preparing a medicament for preventing and/or treating canceration of a hepatitis B patient. The invention also provides a kit for knocking out the SMC1B gene and a method for preparing an SMC1B gene knocked-out cell model. The inventor uses a specific sgRNA sequence to knock out SMC1B gene, so that the tumorigenicity of HBV can be reduced, especially the tumorigenicity of BVrtal 81T/sWl72 mutant strain is reduced very obviously, and the method has important theoretical and practical significance for preventing and treating clinical HBV related diseases. |
priorityDate | 2017-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 285.